MIR4804

Across TCGA pan-cancer cohorts, MIR4804 RNA is linked to patient survival in 10 of 34 cancer types, making it the most broadly survival-associated MIR4804 data layer.

The strongest signal is observed in lung adenocarcinoma (LUAD), where higher MIR4804 RNA is associated with worse overall survival. In most high-consensus cancer types, elevated MIR4804 expression acts as an unfavorable survival marker, although some lineages such as LAML show a favorable association.

LUAD, LUSC, and THCA are the cancer types where MIR4804 RNA most reproducibly stratifies survival.

RNA survival associations by lineage

Ranked by sampling consensus. AUC1 and AUC2 indicate survival in the high- and low-expression groups, respectively; the lower AUC marks the poorer-surviving group. p-values are from the log-rank test.

Lineage	Measure	Split	Stage	AUC1 high	AUC2 low	p	Sampling consensus
LUAD	OS	Tertile	III,IV	0.269	0.680	<.001	72	view →
LUSC	DFS	Tertile	All	0.573	0.763	.006	51	view →
THCA	OS	Tertile	II,III,IV	0.479	0.841	<.001	27	view →
SARC	DFS	Tertile	All	0.384	0.623	.012	18	view →
KICH	DFS	Tertile	All	0.121	0.867	.023	15	view →
ESCA	DFS	Quartile	II,III,IV	0.339	0.596	.004	15	view →
LGG	DFS	Tertile	All	0.722	0.841	.021	12	view →
KIRP	OS	Tertile	All	0.700	0.909	.021	9	view →
OV	DFS	Median	IV	0.224	0.367	.047	6	view →
LAML	DFS	Median	All	0.484	0.242	.033	4	view →

Pink = unfavorable, green = favorable. Showing the 10 strongest of 10 lineages.

MIR4804–LUAD (OS)

Open the LUAD breakdown →